SMS PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of SMS PHARMACEUTICALS have increased by 13.30% YoY .
The Earnings Per Share (EPS) of SMS PHARMACEUTICALS has increased by 39.62 % YoY. |
||
SMS PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 532815|NSE : SMSPHARMA]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹887 Cr | ₹783 Cr | ₹709 Cr | ₹522 Cr | ₹520 Cr |
| Expenses | ₹715 Cr | ₹644 Cr | ₹593 Cr | ₹468 Cr | ₹405 Cr |
| Operating Profit (Excl OI) | ₹172 Cr | ₹139 Cr | ₹117 Cr | ₹55 Cr | ₹115 Cr |
| Other Income | ₹8.35 Cr | ₹6.22 Cr | ₹4.46 Cr | ₹4.91 Cr | ₹5.20 Cr |
| Interest | ₹23 Cr | ₹19 Cr | ₹24 Cr | ₹22 Cr | ₹19 Cr |
| Depreciation | ₹40 Cr | ₹34 Cr | ₹32 Cr | ₹32 Cr | ₹32 Cr |
| Profit Before Tax | ₹117 Cr | ₹92 Cr | ₹66 Cr | ₹5.35 Cr | ₹68 Cr |
| Profit After Tax | ₹88 Cr | ₹67 Cr | ₹49 Cr | ₹3.88 Cr | ₹68 Cr |
| Consolidated Net Profit | ₹102 Cr | ₹69 Cr | ₹50 Cr | ₹-7.06 Cr | ₹62 Cr |
| Earnings Per Share (Rs) | ₹10.89 | ₹7.80 | ₹5.89 | ₹-0.83 | ₹7.35 |
| PAT Margin (%) | 8.78 | 7.96 | 6.43 | 0.70 | 12.25 |
| ROE(%) | 12.49 | 11.91 | 10.16 | 0.83 | 15.41 |
| ROCE(%) | 13.32 | 12.55 | 11.73 | 3.79 | 12.60 |
| Total Debt/Equity(x) | 0.46 | 0.50 | 0.55 | 0.55 | 0.55 |
Key Financials |
||
| Market Cap | : | ₹ 4,484.5 Cr |
| Revenue (TTM) | : | ₹ 897.8 Cr |
| Net Profit(TTM) | : | ₹ 89.5 Cr |
| EPS (TTM) | : | ₹ 9.5 |
| P/E (TTM) | : | 50.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SMS PHARMACEUTICALS | -0.9% | 34.7% | 60.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.3% | -3.1% | 12.8% |
| DIVIS LABORATORIES | -1.3% | 2.2% | 57.5% |
| TORRENT PHARMACEUTICALS | -1.3% | -2.4% | 33.3% |
| CIPLA | 0.2% | -2.5% | -9.1% |
| DR REDDYS LABORATORIES | 3.3% | 6.1% | -6.5% |
| MANKIND PHARMA | 3.4% | 6.6% | -4.8% |
| LUPIN | -1.9% | -5.3% | 2.8% |
| ZYDUS LIFESCIENCES | 2.2% | 0.7% | 15.9% |
SMS PHARMACEUTICALS Revenues
[BOM: 532815|NSE : SMSPHARMA]
| Y-o-Y | 13.30 % |
| 5 Yr CAGR | 14.29 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹887 Cr | 13.30 | |
| Mar2025 | ₹783 Cr | 10.36 | |
| Mar2024 | ₹709 Cr | 35.86 | |
| Mar2023 | ₹522 Cr | 0.42 | |
| Mar2022 | ₹520 Cr | - | |
SMS PHARMACEUTICALS Operating Profit
[BOM: 532815|NSE : SMSPHARMA]
| Y-o-Y | 23.42 % |
| 5 Yr CAGR | 10.61 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹172 Cr | 23.42 | |
| Mar2025 | ₹139 Cr | 19.04 | |
| Mar2024 | ₹117 Cr | 114.10 | |
| Mar2023 | ₹55 Cr | -52.42 | |
| Mar2022 | ₹115 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 8.90 % |
| 5 Yr CAGR | -3.23 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 19.34% | 8.90 | |
| Mar2025 | 17.76% | 7.90 | |
| Mar2024 | 16.46% | 57.51 | |
| Mar2023 | 10.45% | -52.61 | |
| Mar2022 | 22.05% | - | |
SMS PHARMACEUTICALS Profit After Tax
[BOM: 532815|NSE : SMSPHARMA]
| Y-o-Y | 47.52 % |
| 5 Yr CAGR | 13.15 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹102 Cr | 47.52 | |
| Mar2025 | ₹69 Cr | 38.75 | |
| Mar2024 | ₹50 Cr | Positive | |
| Mar2023 | ₹-7.06 Cr | Negative | |
| Mar2022 | ₹62 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 10.30 % |
| 5 Yr CAGR | -7.99 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 8.78 % | 10.30 | |
| Mar2025 | 7.96 % | 23.79 | |
| Mar2024 | 6.43 % | 818.57 | |
| Mar2023 | 0.7 % | -94.29 | |
| Mar2022 | 12.25 % | - | |
SMS PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 532815|NSE : SMSPHARMA]
| Y-o-Y | 39.62 % |
| 5 Yr CAGR | 10.33 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹11 | 39.62 | |
| Mar2025 | ₹7.80 | 32.43 | |
| Mar2024 | ₹5.89 | Positive | |
| Mar2023 | ₹-0.83 | Negative | |
| Mar2022 | ₹7.35 | - | |
SMS PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 532815|NSE : SMSPHARMA]
| Y-o-Y | 6.14 % |
| 5 Yr CAGR | 1.40 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 13.32% | 6.14 | |
| Mar2025 | 12.55% | 6.99 | |
| Mar2024 | 11.73% | 209.50 | |
| Mar2023 | 3.79% | -69.92 | |
| Mar2022 | 12.6% | - | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹478.6 |
| Current MarketCap | : | ₹ 4,484.5 Cr |
| Updated EOD on | : | Sep 29,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | -0.9% |
34.7% |
60.8% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
SMS PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | -0.9% | -0.1% | 14.5% |
You may also like the below Video Courses
FAQ about SMS PHARMACEUTICALS Financials
How the annual revenues of SMS PHARMACEUTICALS have changed ?
The Revenues of SMS PHARMACEUTICALS have increased by 13.30% YoY .
How the Earnings per Share (EPS) of SMS PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of SMS PHARMACEUTICALS has increased by 39.62 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs